Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Bolt Biotherapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −1 vs. Q4 2023
- Shares held
- 24.0M
- −124.9K (−0.5%) vs. Q4 2023
- Total value
- $33.6M
- +$6.58M (+24.4%) vs. Q4 2023
- New holders
- 2
- 8 more added
- Sold out
- 3
- 12 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BOLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $2.31M |
| Q1 2026 | 24 | $2.49M |
| Q4 2025 | 21 | $3.30M |
| Q3 2025 | 24 | $4.28M |
| Q2 2025 | 25 | $5.10M |
| Q1 2025 | 30 | $7.33M |
| Q4 2024 | 38 | $9.99M |
| Q3 2024 | 32 | $12.2M |
| Q2 2024 | 37 | $17.0M |
| Q1 2024 | 39 | $33.6M |
| Q4 2023 | 40 | $27.0M |
| Q3 2023 | 35 | $25.5M |
| Q2 2023 | 40 | $32.1M |
| Q1 2023 | 41 | $32.4M |
| Q4 2022 | 44 | $26.8M |
| Q3 2022 | 56 | $39.7M |
| Q2 2022 | 62 | $54.8M |
| Q1 2022 | 66 | $79.3M |
| Q4 2021 | 62 | $164.6M |
| Q3 2021 | 72 | $449.1M |
| Q2 2021 | 61 | $513.8M |
| Q1 2021 | 70 | $1.04B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Bolt Biotherapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 3,521,291 | $4.93M | 0.39% | 00.0% | Unchanged |
| Tang Capital Management LLC | 3,420,000 | $4.79M | 0.50% | −232,244−6.4% | Reduced |
| Sofinnova Investments, Inc. | 2,754,437 | $3.86M | 0.23% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,415,728 | $3.38M | 0.00% | −43,230−1.8% | Reduced |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $2.65M | 1.70% | 00.0% | Unchanged |
| Newtyn Management, LLC | 1,700,000 | $2.38M | 0.47% | +146,465+9.4% | Added |
| OrbiMed Advisors LLC | 1,541,000 | $2.16M | 0.04% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 1,166,952 | $1.63M | 1.51% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 1,049,153 | $1.47M | 0.23% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,037,603 | $1.45M | 0.00% | +106,474+11.4% | Added |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $1.01M | 0.09% | 00.0% | Unchanged |
| Acuitas Investments, LLC | 517,952 | $725.1K | 0.37% | +58,497+12.7% | Added |
| Renaissance Technologies LLC | 517,637 | $725.0K | 0.00% | +72,364+16.3% | Added |
| Adage Capital Partners GP, L.L.C. | 500,000 | $700.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 347,567 | $486.7K | 0.00% | −2,597−0.7% | Reduced |
| BlackRock Inc. | 254,958 | $356.9K | 0.00% | −2,313−0.9% | Reduced |
| Bridgeway Capital Management, LLC | 111,200 | $155.7K | 0.00% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 96,673 | $135.3K | 0.02% | 00.0% | Unchanged |
| FMR LLC | 78,899 | $110.5K | 0.00% | −294−0.4% | Reduced |
| Squarepoint Ops LLC | 78,020 | $109.2K | 0.00% | −1,752−2.2% | Reduced |
| State Street Corp | 47,437 | $66.4K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 45,956 | $64.3K | 0.00% | −1,051−2.2% | Reduced |
| Northern Trust Corp | 41,005 | $57.4K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 35,200 | $49.3K | 0.00% | +23,000+188.5% | Added |
| Morgan Stanley | 24,687 | $34.6K | 0.00% | −54,707−68.9% | Reduced |
| Two Sigma Securities, LLC | 23,814 | $33.3K | 0.00% | −40,418−62.9% | Reduced |
| Advisor Group Holdings, Inc. | 15,000 | $21.0K | 0.00% | +11,022+277.1% | Added |
| XTX Topco Ltd | 12,826 | $18.0K | 0.00% | −6,326−33.0% | Reduced |
| UBS Group AG | 12,171 | $17.0K | 0.00% | +4,520+59.1% | Added |
| Virtu Financial LLC | 10,938 | $15.0K | 0.00% | +10,938 | New |
| Tower Research Capital LLC (TRC) | 5,546 | $7.76K | 0.00% | −2,690−32.7% | Reduced |
| ADAR1 Capital Management, LLC | 5,000 | $7.00K | 0.00% | +5,000 | New |
| JPMorgan Chase & Co | 840 | $1.18K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 628 | $879 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 211 | $295 | 0.00% | +4+1.9% | Added |
| Barclays PLC | 139 | $195 | 0.00% | 00.0% | Unchanged |
| Salem Investment Counselors Inc | 40 | $56 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1 | $0 | 0.00% | −464−99.8% | Reduced |
| Privium Fund Management (UK) Ltd | 0 | $0 | 0.00% | −116,516−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −56,264−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −2,307−100.0% | Sold out |